85+ Publications and Counting: The Clinical Evidence Behind Longvida®

Curcumin is one of the most widely researched botanicals in the nutraceutical space, yet not all curcumin ingredients are supported equally by clinical evidence.

Longvida® stands out as one of the few curcumin branded ingredients backed by 85+ scientific publications, spanning human clinical trials, pharmacokinetic studies and mechanistic research. This strong foundation supports credible benefits.

The strength of the Longvida® portfolio lies not only in the quantity, but also in the quality and consistency of its research. Studies have been conducted across recognised academic and clinical institutions, focusing on bioavailability and targeted delivery¹, overcoming traditional challenges associated with poor stability and efficacy. 

One area where Longvida®’s scientific depth is particularly valuable is cognitive decline. Longvida®, the “Cognitive Curcumin of Choice®” is supported by multiple clinical exploring its role in brain health. Its ability to deliver free curcumin into circulation, combined with research exploring blood–brain barrier permeability¹, positions it as a leading option for developers targeting the growing nootropic and cognitive wellness markets. This makes it especially relevant as demand increases for ingredients supported by clinically meaningful outcomes.

Beyond cognitive health, research on Longvida® highlights its potential to support vascular function², joint health³, metabolic health⁴ and exercise recovery⁵ and more, enabling formulators to develop targeted solutions across multiple health categories. Recent findings also point to benefits in glucose homeostasis and gut microbiota modulation, further expanding its relevance in emerging health areas.

Alongside its scientific credentials, Longvida® is produced as part of a sustainable and traceable supply chain, with initiatives focused on responsible sourcing, environmental impact reduction and community support, helping brands meet growing consumer expectations around transparency and sustainability.

For more information, download our Longvida® Product Profile Sheet here or contact us.

_{References
(1) Gota et al. (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in patients and healthy volunteers.
(2) Santos-Parker et al. (2015) biomarkers of aging and age-associated disease curcumin supplementation improves vascular endothelial function in middle-aged and older adults. doi.org/10.1093/geront/gnv554.01.
(3) Gupte PA et al. (2019) Evaluation of the efficacy and safety of capsule Longvida® Optimized Curcumin (solid lipid curcumin particles) in knee: A pilot clinical study.doi: 10.2147/JIR.S205390.
(4) Lucas Fornari Laurindo et al. (2021) Curcuma longa and curcumin on metabolic syndrome: a systematic review. LCM Longhua Chinese Medicine Vol 4.
(5) McFarlin et al. (2016) Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin.doi:10.1016/j.bbacli.2016.02}